Increased serum IL-36γ levels are associated with disease severity in myasthenia gravis patients.

Qiu-Xia ZhangYue LiShu-Min JiangLin-Jie ZhangMing YiJing WangYuan QiLi YangChun-Sheng Yang

Published in: BMC neurology (2020)

The serum levels of IL-36γ in patients with MG were increased and positively correlated with disease severity and may thus have potential as a serological MG marker.

Keyphrases

myasthenia gravis
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
climate change
patient reported